President Donald Trump speaks from the Oval Office to announce that Pfizer has agreed to take measures to lower U.S. drug prices, including selling its existing drugs to Medicaid patients at the lowest price offered in other developed nations. ...

President Donald Trump on Tuesday announces an agreement with Pfizer to voluntarily sell its medications at lower prices, as his administration pushes to link U.S. drug prices to the cheaper prices paid abroad. Pfizer CEO Albert Bourla will be in attendance, a White House official said. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/42d859g » Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision » Subscribe to CNBC: https://cnb.cx/SubscribeCNBC » Watch CNBC on ...

America’s drug prices were more than three times the average in other rich countries in 2022. As a consequence, it coughs up around 70% of global pharmaceutical profits from about half of global sales. This is partly because of how the market is organised https://t.co/eyJHSfPEB3 ...

Pharmaceutical Industry & Pricing - The pharmaceutical industry faces potential disruption as Trump announced plans to reduce drug prices in the US by 1500% [1] - A 1500% reduction in drug prices represents a significant shift in the US pharmaceutical market, potentially impacting company revenues and profitability [1]

JUST IN: 🇺🇸 President Trump says US will reduce drug prices by 1500%. https://t.co/7tyma9f9cQ ...

Pricing Strategy - Eli Lilly is in discussions to increase drug prices in Europe, beginning with the weight-loss drug Mounjaro in the U_K [1] - The price increase aims to align with President Trump's objective of reducing drug prices in the U_S [1]

European governments control drug prices in various ways—Britain is particularly strict, refusing to pay for medicines that do not meet a threshold of cost-effectiveness. But AstraZeneca’s boss is not afraid of a scrap https://t.co/3koNEJQOxS ...

Merck is considering selling medicines directly to patients in the US, joining drugmakers seeking to bypass middlemen following President Trump’s demand for lower drug prices https://t.co/K3WobcCp51 ...

Industry Focus - The pharmaceutical industry is facing increasing pressure to lower drug prices [1] - The Trump administration is escalating demands for drug companies to reduce prices [1]

Industry Pressure - Pharma companies are facing immediate pressure to cut down drug prices [1] Political Influence - Trump is urging pharma companies to immediately cut down drug prices [1]